biochemist engineer biomedical engineer
Julian Paul Breillatt Jr. was born on March 2, 1938, in Pensacola, Florida, to Julian Paul Breillatt and Ruth Walser Breillatt. His professional life developed through biochemistry, biomedical engineering, and applied medical research, with early work connected to Oak Ridge, Tennessee, and later research leadership in the pharmaceutical and health-care industries.
Breillatt studied biochemistry at the University of California, completing a Bachelor of Arts degree in 1959. He continued his education at the University of Utah, where he earned a Doctor of Philosophy in biochemistry in 1967. His academic training provided the foundation for a career combining biochemical research with the development of biomedical materials, blood-processing systems, and therapeutic technologies.
Breillatt began his research career at Oak Ridge National Laboratory, where he served as a research associate and later as a research scientist. He also served as acting director of a molecular anatomy program and worked as a senior research chemist. In 1977 and 1978 he was a research supervisor at E. I. du Pont de Nemours and Company. He joined Baxter Healthcare Corporation as a research scientist in 1986 and advanced to senior research director and research director. His industrial research focused on blood collection and filtration systems, leukocyte removal, dialysis-related biocompatibility, therapeutic-fluid processing, and biomedical materials. He was a co-author of a 1984 New England Journal of Medicine study on complement activation and hypersensitivity reactions to dialysis membranes and was named as an inventor on patents covering fibrin sheets, centrifuge rotors, bioaffinity and ion-exchange separations, controlled-release compositions, leukodepletion filters, flexible blood-collection filters, porous-membrane blood-collection systems, and pathogen-inactivation processes. By 2009 he was described as a retired senior research director.
Developed and co-developed biomedical technologies involving blood filtration, leukocyte removal, blood collection, dialysis-related materials, therapeutic-fluid processing, and biomedical fibrin materials, resulting in a substantial body of patented work.
Co-authored a landmark 1984 study examining complement activation and hypersensitivity reactions associated with dialysis membranes.
(Co-authored with R. M. Hakim, J. M. Lazarus, and F. K. Po...)
1984(Further United States patent in the porous-membrane blood...)
2004(United States patent naming Julian P. Breillatt Jr. as in...)
1973(United States patent naming Julian P. Breillatt Jr. as an...)
1976(Patent work associated with Julian P. Breillatt and colla...)
1993(Patent naming Julian P. Breillatt Jr. and Sharon L. Pokro...)
1998(Patent naming Julian P. Breillatt Jr. and Sharon L. Pokro...)
1999(Patent naming Julian P. Breillatt Jr. among the inventors...)
2002(Patent naming Julian P. Breillatt Jr. and Shmuel Sternber...)
2003Julian Paul Breillatt Jr. was a member of The Church of Jesus Christ of Latter-day Saints and held extensive ecclesiastical responsibilities, including service as a bishop, patriarch, stake leader, temple presidency counselor, and temple president.
Breillatt was active in The Church of Jesus Christ of Latter-day Saints. His documented service included work as a seminary teacher, bishop, high councilor, stake president's counselor, patriarch, counselor in the Santo Domingo Dominican Republic Temple presidency, counselor in the Chicago Illinois Temple presidency, and president of the Accra Ghana Temple.
Breillatt was the son of Julian Paul Breillatt and Ruth Walser Breillatt. He was married to Gaye Sorensen Breillatt, who served with him as matron of the Accra Ghana Temple.
